Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.
Young adult cancer survivors reported poorer physical and emotional health but better social health in a study by Northwestern Medicine scientists.
A mathematical model can predict whether a tumor has a gene mutation associated with a favorable prognosis for glioblastoma patients.
Prostate cancer cells producing too much PIM1 are particularly sensitive to the inhibition of a protein called polo-like kinase (PLK1).
Metformin, a drug used to lower insulin levels in diabetics, has been shown to halt tumor progression by cutting cancer cells’ energy supply.
A new Northwestern Medicine study found a gel form of tamoxifen applied to the breasts of women with noninvasive breast cancer has fewer side effects than the same drug taken in oral form.
Scientists from Northwestern Medicine and the University of Chicago identified elevated levels of a regulatory protein called beta-catenin in the T-cells of patients with colon cancer.
A recently published Northwestern Medicine study uses math models based on the physical interactions within cells to make predictions of how gene transcription might be effected.
Radioembolization may offer an alternative to chemotherapy for breast cancer patients whose tumors have spread to the liver.
One of more than a dozen connected papers to be published in the American Journal of Public Health, a recent study has shown that Lesbian, Gay, Bisexual or Transgender youths make an increased number of choices that elevate their risk of cancer.